Jazz Pharmaceuticals plc Increase (Decrease) in Accounts Payable
Jazz Pharmaceuticals plc (JAZZ) reported Increase (Decrease) in Accounts Payable of $7.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-03
- Jazz Pharmaceuticals plc increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $28.50M.
- Jazz Pharmaceuticals plc increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$21.40M, a 212.04% decline year-over-year.
- Jazz Pharmaceuticals plc increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$28.97M.
- Jazz Pharmaceuticals plc increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $62.32M.
- Jazz Pharmaceuticals plc increase (decrease) in accounts payable for fiscal 2025 was $39.85M.
- Jazz Pharmaceuticals plc increase (decrease) in accounts payable for fiscal 2024 was -$20.07M, a 309.03% decline from fiscal 2023.
- Jazz Pharmaceuticals plc increase (decrease) in accounts payable for fiscal 2023 was $9.60M.
- Jazz Pharmaceuticals plc increase (decrease) in accounts payable for fiscal 2022 was -$11.22M, a 119.69% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $7.10M 10-Q · filed 2026-08-03 | -$21.87M derived: sum of 3 quarters · filed 2026-08-03 | $40.45M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | -$21.40M 10-Q · filed 2026-05-05 | -$50.37M derived: sum of 2 quarters · filed 2026-05-05 | $11.95M derived: sum of 3 quarters · filed 2026-05-05 | -$649.00K derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | -$28.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $33.35M derived: sum of 2 quarters · filed 2026-02-24 | $20.75M derived: sum of 3 quarters · filed 2026-08-03 | $39.85M 10-K · filed 2026-02-24 | ||
| 2025-09-30 | $62.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $49.72M derived: sum of 2 quarters · filed 2026-08-03 | $68.82M 10-Q · filed 2025-11-05 | $65.69M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | -$12.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $6.50M 10-Q · filed 2026-08-03 | $6.46M 10-Q · filed 2025-08-06 | $3.37M derived: sum of 3 quarters · filed 2026-08-03 | -$9.43M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-03-31 | $19.10M 10-Q · filed 2026-05-05 | $19.13M 10-Q · filed 2025-05-07 | $15.96M derived: sum of 2 quarters · filed 2026-05-05 | $3.17M derived: sum of 3 quarters · filed 2026-05-05 | $18.62M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$15.93M derived: sum of 2 quarters · filed 2026-02-24 | -$476.00K derived: sum of 3 quarters · filed 2026-02-24 | -$20.07M 10-K · filed 2026-02-24 | ||
| 2024-09-30 | -$12.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.66M derived: sum of 2 quarters · filed 2025-11-05 | -$16.94M 10-Q · filed 2025-11-05 | -$25.04M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | $15.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$4.15M 10-Q · filed 2025-08-06 | -$12.25M derived: sum of 3 quarters · filed 2026-02-24 | -$2.01M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | -$19.60M 10-Q · filed 2025-05-07 | -$27.70M derived: sum of 2 quarters · filed 2026-02-24 | -$17.46M derived: sum of 3 quarters · filed 2026-02-24 | -$44.28M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | -$8.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.14M derived: sum of 2 quarters · filed 2026-02-24 | -$24.68M derived: sum of 3 quarters · filed 2026-02-24 | $9.60M 10-K · filed 2026-02-24 | ||
| 2023-09-30 | $10.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$16.58M derived: sum of 2 quarters · filed 2024-11-07 | $17.70M 10-Q · filed 2024-11-07 | $2.29M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-06-30 | -$26.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $7.46M 10-Q · filed 2024-08-01 | -$7.95M derived: sum of 3 quarters · filed 2025-02-26 | $21.01M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-03-31 | $34.29M 10-Q · filed 2024-05-02 | $18.87M derived: sum of 2 quarters · filed 2025-02-26 | $47.83M derived: sum of 3 quarters · filed 2025-02-26 | $50.68M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2022-12-31 | -$15.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $13.55M derived: sum of 2 quarters · filed 2025-02-26 | $16.39M derived: sum of 3 quarters · filed 2025-02-26 | -$11.22M 10-K · filed 2025-02-26 | ||
| 2022-09-30 | $28.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $31.80M derived: sum of 2 quarters · filed 2023-11-08 | $4.19M 10-Q · filed 2023-11-08 | $42.04M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$24.77M 10-Q · filed 2023-08-09 | $13.08M derived: sum of 3 quarters · filed 2024-02-28 | $12.94M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | -$27.62M 10-Q · filed 2023-05-10 | $10.24M derived: sum of 2 quarters · filed 2024-02-28 | $10.10M derived: sum of 3 quarters · filed 2024-02-28 | -$21.89M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $37.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $37.71M derived: sum of 2 quarters · filed 2024-02-28 | $5.73M derived: sum of 3 quarters · filed 2024-02-28 | $57.02M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | -$142.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$32.13M derived: sum of 2 quarters · filed 2022-11-09 | $19.17M 10-Q · filed 2022-11-09 | -$20.41M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | -$31.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $19.31M 10-Q · filed 2022-08-03 | -$20.27M derived: sum of 3 quarters · filed 2023-03-01 | -$4.89M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $51.29M 10-Q · filed 2022-05-04 | $11.71M derived: sum of 2 quarters · filed 2023-03-01 | $27.09M derived: sum of 3 quarters · filed 2023-03-01 | $12.75M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | -$39.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$24.20M derived: sum of 2 quarters · filed 2023-03-01 | -$38.54M derived: sum of 3 quarters · filed 2023-03-01 | -$18.93M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | $15.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.04M derived: sum of 2 quarters · filed 2021-11-09 | $20.64M 10-Q · filed 2021-11-09 | -$3.69M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | -$14.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $5.26M 10-Q · filed 2021-08-03 | -$19.07M derived: sum of 3 quarters · filed 2022-03-01 | $24.13M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $19.60M 10-Q · filed 2021-05-04 | -$4.73M derived: sum of 2 quarters · filed 2022-03-01 | $38.47M derived: sum of 3 quarters · filed 2022-03-01 | $22.82M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | -$24.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $18.87M derived: sum of 2 quarters · filed 2022-03-01 | $3.22M derived: sum of 3 quarters · filed 2022-03-01 | $4.77M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $43.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $27.55M derived: sum of 2 quarters · filed 2020-11-02 | $29.10M 10-Q · filed 2020-11-02 | $36.03M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-06-30 | -$15.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$14.10M 10-Q · filed 2020-08-04 | -$7.17M derived: sum of 3 quarters · filed 2021-02-23 | -$4.43M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-03-31 | $1.55M 10-Q · filed 2020-05-05 | $8.48M derived: sum of 2 quarters · filed 2021-02-23 | $11.22M derived: sum of 3 quarters · filed 2021-02-23 | -$4.54M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2018-12-31 | $6.92M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $9.67M derived: sum of 2 quarters · filed 2021-02-23 | -$6.10M derived: sum of 3 quarters · filed 2021-02-23 | $17.04M 10-K · filed 2021-02-23 | ||
| 2018-09-30 | $2.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$13.02M derived: sum of 2 quarters · filed 2019-11-05 | $10.12M 10-Q · filed 2019-11-05 | $4.20M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-06-30 | -$15.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $7.37M 10-Q · filed 2019-08-06 | $1.46M derived: sum of 3 quarters · filed 2020-02-25 | $2.24M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-31 | $23.14M 10-Q · filed 2019-05-07 | $17.22M derived: sum of 2 quarters · filed 2020-02-25 | $18.00M derived: sum of 3 quarters · filed 2020-02-25 | $17.48M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2017-12-31 | -$5.92M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$5.13M derived: sum of 2 quarters · filed 2020-02-25 | -$5.65M derived: sum of 3 quarters · filed 2020-02-25 | $214.00K 10-K · filed 2020-02-25 | ||
| 2017-09-30 | $783.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $265.00K derived: sum of 2 quarters · filed 2018-11-06 | $6.13M 10-Q · filed 2018-11-06 | $10.78M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-06-30 | -$518.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $5.35M 10-Q · filed 2018-08-07 | $10.00M derived: sum of 3 quarters · filed 2019-02-26 | -$516.00K derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-03-31 | $5.87M 10-Q · filed 2018-05-08 | $10.51M derived: sum of 2 quarters · filed 2019-02-26 | $2.00K derived: sum of 3 quarters · filed 2019-02-26 | -$4.44M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2016-12-31 | $4.65M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$5.86M derived: sum of 2 quarters · filed 2019-02-26 | -$10.30M derived: sum of 3 quarters · filed 2019-02-26 | $361.00K 10-K · filed 2019-02-26 | ||
| 2016-09-30 | -$10.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$14.95M derived: sum of 2 quarters · filed 2017-11-07 | -$4.29M 10-Q · filed 2017-11-07 | -$11.39M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-06-30 | -$4.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $6.22M 10-Q · filed 2017-08-08 | -$882.00K derived: sum of 3 quarters · filed 2018-02-27 | $1.81M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | $10.66M 10-Q · filed 2017-05-09 | $3.56M derived: sum of 2 quarters · filed 2018-02-27 | $6.25M derived: sum of 3 quarters · filed 2018-02-27 | $5.08M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | -$7.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$4.41M derived: sum of 2 quarters · filed 2018-02-27 | -$5.58M derived: sum of 3 quarters · filed 2018-02-27 | -$2.28M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $1.52M derived: sum of 2 quarters · filed 2016-11-08 | $4.83M 10-Q · filed 2016-11-08 | $725.00K derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | -$1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $2.13M 10-Q · filed 2016-08-09 | -$1.97M derived: sum of 3 quarters · filed 2017-02-28 | -$4.28M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-03-31 | $3.30M 10-Q · filed 2016-05-10 | -$798.00K derived: sum of 2 quarters · filed 2017-02-28 | -$3.11M derived: sum of 3 quarters · filed 2017-02-28 | -$43.24M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2014-12-31 | -$4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$6.41M derived: sum of 2 quarters · filed 2017-02-28 | -$46.55M derived: sum of 3 quarters · filed 2017-02-28 | -$37.97M 10-K · filed 2017-02-28 | ||
| 2014-09-30 | -$2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$42.44M derived: sum of 2 quarters · filed 2015-11-09 | -$33.87M 10-Q · filed 2015-11-09 | -$35.45M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-06-30 | -$40.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$31.55M 10-Q · filed 2015-08-05 | -$33.14M derived: sum of 3 quarters · filed 2016-02-23 | -$31.17M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-03-31 | $8.58M 10-Q · filed 2015-05-07 | $7.00M derived: sum of 2 quarters · filed 2016-02-23 | $8.96M derived: sum of 3 quarters · filed 2016-02-23 | -$2.49M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2013-12-31 | -$1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $382.00K derived: sum of 2 quarters · filed 2016-02-23 | -$11.07M derived: sum of 3 quarters · filed 2016-02-23 | $5.09M 10-K · filed 2016-02-23 | ||
| 2013-09-30 | $1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$9.49M derived: sum of 2 quarters · filed 2014-11-04 | $6.67M 10-Q · filed 2014-11-04 | $1.93M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | -$11.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $4.71M 10-Q · filed 2014-08-05 | -$36.00K derived: sum of 3 quarters · filed 2015-02-24 | -$13.94M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-03-31 | $16.16M 10-Q · filed 2014-05-08 | $11.41M derived: sum of 2 quarters · filed 2015-02-24 | -$2.49M derived: sum of 3 quarters · filed 2015-02-24 | $4.22M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2012-12-31 | -$4.74M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$18.65M derived: sum of 2 quarters · filed 2015-02-24 | -$11.94M derived: sum of 3 quarters · filed 2015-02-24 | -$7.29M 10-K · filed 2015-02-24 | ||
| 2012-09-30 | -$13.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | -$7.19M derived: sum of 2 quarters · filed 2013-11-05 | -$2.54M 10-Q · filed 2013-11-05 | -$5.88M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-06-30 | $6.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $11.36M 10-Q · filed 2013-08-06 | $8.03M derived: sum of 3 quarters · filed 2014-02-25 | $11.83M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-03-31 | $4.65M 10-Q · filed 2013-05-07 | $1.31M derived: sum of 2 quarters · filed 2014-02-25 | $5.11M derived: sum of 3 quarters · filed 2014-02-25 | $6.13M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2011-12-31 | -$3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $464.00K derived: sum of 2 quarters · filed 2014-02-25 | $1.48M derived: sum of 3 quarters · filed 2014-02-25 | $2.08M 10-K · filed 2014-02-25 | ||
| 2011-09-30 | $3.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $4.82M derived: sum of 2 quarters · filed 2012-11-09 | $5.41M 10-Q · filed 2012-11-09 | $4.57M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $1.62M 10-Q · filed 2012-08-07 | $774.00K derived: sum of 3 quarters · filed 2013-02-26 | -$1.74M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-03-31 | $599.00K 10-Q · filed 2012-05-08 | -$243.00K derived: sum of 2 quarters · filed 2013-02-26 | -$2.75M derived: sum of 3 quarters · filed 2013-02-26 | |||
| 2010-12-31 | -$842.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$3.35M derived: sum of 2 quarters · filed 2013-02-26 | $891.00K 10-K · filed 2013-02-26 | |||
| 2010-09-30 | -$2.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $1.73M 10-Q · filed 2011-11-08 | ||||
| 2010-06-30 | $4.25M 10-Q · filed 2011-08-03 | |||||
| 2009-12-31 | -$3.58M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |